Hanson & Doremus Investment Management Regeneron Pharmaceuticals, Inc. Transaction History

Hanson & Doremus Investment Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	BUY	$573.97 - $724.32 $17,219 - $21,729	30 New	30 $21,000
Q1 2022 Apr 22, 2022	SELL	$595.12 - $698.43 $595 - $698	-1 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$574.03 - $680.96 $574 - $680	1 New	1 $0
Q2 2021 Jul 22, 2021	SELL	$472.8 - $558.54 $472 - $558	-1 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$446.73 - $548.2 $446 - $548	1 New	1 $0

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

Stay updated on Hanson & Doremus Investment Management with notifications on news.